Mergers and acquisition (M&A) deals are surging in biopharma, with the value of the top 10 M&A transactions in 2023 totaling over $115 billion. This sum far exceeds those of the past few years.
CCC sat down with Doreen P. Alberts for a discussion on how smaller life science companies can improve the way their employees search for and utilize scientific content.
Doreen Alberts, an independent life sciences consultant with 30+ years’ experience managing information resources, offers advice on how to make it easier for researchers to get quick, compliant access to scientific articles.
Drug development is a lengthy process, and it’s important to be on top of scientific literature to ensure that you are always moving in the right direction.
Medical Affairs teams play a critical role in advancing scientific knowledge, supporting HCPs, ensuring product safety and efficacy, and contributing to the success of pharmaceutical companies in delivering innovative therapies to patients.
It takes more than having a good idea to find a drug, so the more time a drug discoverer can save in comprehensively identifying all the relevant information, evidence and data, the better.
Sharing content unlawfully undermines the culture of integrity that is valued by research organizations. While internal resources are usually limited in smaller companies, there are several ways to outsource copyright compliance efforts.
Mary Ellen Bates shares the inside story of an information scientist working among a team of data professionals – with his tips for collaborative success.
CCC recently assembled a panel of expert leaders in publishing and medical communications for a broad discussion on copyright as it pertains to the work of medical communications professionals.